Literature DB >> 28965864

Minor spliceosome and disease.

Bhupendra Verma1, Maureen V Akinyi1, Antto J Norppa1, Mikko J Frilander2.   

Abstract

The U12-dependent (minor) spliceosome excises a rare group of introns that are characterized by a highly conserved 5' splice site and branch point sequence. Several new congenital or somatic diseases have recently been associated with mutations in components of the minor spliceosome. A common theme in these diseases is the detection of elevated levels of transcripts containing U12-type introns, of which a subset is associated with other splicing defects. Here we review the present understanding of minor spliceosome diseases, particularly those associated with the specific components of the minor spliceosome. We also present a model for interpreting the molecular-level consequences of the different diseases.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Keywords:  Cryptic splice sites; Exon skipping; Human diseases; Intron retention; Minor spliceosome; Pre-mRNA splicing; U12-type introns

Mesh:

Substances:

Year:  2017        PMID: 28965864     DOI: 10.1016/j.semcdb.2017.09.036

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  30 in total

1.  RNA Binding Motif Protein 48 Is Required for U12 Splicing and Maize Endosperm Differentiation.

Authors:  Fang Bai; Jacob Corll; Donya N Shodja; Ruth Davenport; Guanqiao Feng; Janaki Mudunkothge; Christian J Brigolin; Federico Martin; Gertraud Spielbauer; Chi-Wah Tseung; Amy E Siebert; W Brad Barbazuk; Shailesh Lal; A Mark Settles
Journal:  Plant Cell       Date:  2019-02-13       Impact factor: 11.277

2.  Profiling of cis- and trans-acting factors supporting noncanonical splice site activation.

Authors:  Steffen Erkelenz; Gereon Poschmann; Johannes Ptok; Lisa Müller; Heiner Schaal
Journal:  RNA Biol       Date:  2020-08-05       Impact factor: 4.652

3.  Splicing efficiency of minor introns in a mouse model of SMA predominantly depends on their branchpoint sequence and can involve the contribution of major spliceosome components.

Authors:  Valentin Jacquier; Manon Prévot; Thierry Gostan; Rémy Bordonné; Sofia Benkhelifa-Ziyyat; Martine Barkats; Johann Soret
Journal:  RNA       Date:  2021-12-10       Impact factor: 4.942

4.  Alternative Splicing in Human Biology and Disease.

Authors:  Daniel Jutzi; Marc-David Ruepp
Journal:  Methods Mol Biol       Date:  2022

Review 5.  RNA-binding proteins of COSMIC importance in cancer.

Authors:  Peter S Choi; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

Review 6.  Roles and mechanisms of alternative splicing in cancer - implications for care.

Authors:  Sophie C Bonnal; Irene López-Oreja; Juan Valcárcel
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

7.  Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons.

Authors:  Erkan Y Osman; Meaghan Van Alstyne; Pei-Fen Yen; Francesco Lotti; Zhihua Feng; Karen Ky Ling; Chien-Ping Ko; Livio Pellizzoni; Christian L Lorson
Journal:  JCI Insight       Date:  2020-06-18

Review 8.  Alternative Splicing of ALS Genes: Misregulation and Potential Therapies.

Authors:  Benedetta Perrone; Valentina La Cognata; Teresa Sprovieri; Carmine Ungaro; Francesca Luisa Conforti; Sebastiano Andò; Sebastiano Cavallaro
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

9.  Lowry-Wood syndrome: further evidence of association with RNU4ATAC, and correlation between genotype and phenotype.

Authors:  Ivan Shelihan; Sophie Ehresmann; Cinzia Magnani; Francesca Forzano; Chiara Baldo; Nicola Brunetti-Pierri; Philippe M Campeau
Journal:  Hum Genet       Date:  2018-10-27       Impact factor: 4.132

Review 10.  The Molecular Genetics of Myeloproliferative Neoplasms.

Authors:  Anna E Marneth; Ann Mullally
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.